MOTS-c vs SS-31: A Research Comparison

MOTS-c and SS-31 are mitochondrial-targeted research peptides with distinct structures, origins, and mechanisms of action. MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by mitochondrial DNA and studied primarily in metabolic signaling, AMPK activation, glucose metabolism, insulin sensitivity, and cellular energy homeostasis, while SS-31 is a synthetic tetrapeptide that selectively interacts with cardiolipin in the inner mitochondrial membrane and is investigated for mitochondrial membrane stability, electron transport, ATP production, oxidative stress, and mitochondrial bioenergetics. Their differences involve AMPK and metabolic signaling, cardiolipin interactions, mitochondrial respiration, reactive oxygen species, glucose utilization, cellular stress responses, and energy metabolism, making them distinct models for mitochondrial biology, metabolic research, and cellular bioenergetics.

Key Difference

• Peptide structure: MOTS-c is a 16-amino-acid peptide with the sequence MRWQEMGYIFYPRKLR; SS-31 is a synthetic 4-amino-acid tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH₂.
• Molecular origin: MOTS-c is a naturally occurring mitochondrial-derived peptide encoded within the mitochondrial MT-RNR1 gene; SS-31 is an engineered aromatic-cationic peptide belonging to the Szeto-Schiller peptide class.
• Site of action: MOTS-c functions primarily as a signaling molecule capable of participating in mitochondrial-to-nuclear communication; SS-31 preferentially associates with the inner mitochondrial membrane through interactions with cardiolipin.
• Primary mechanism: MOTS-c is strongly associated with AMPK-mediated metabolic and cellular stress signaling; SS-31 primarily modulates cardiolipin-associated membrane processes, mitochondrial respiration, and oxidative phosphorylation.
• Metabolic regulation: MOTS-c has a stronger connection to glucose utilization, insulin sensitivity, skeletal-muscle metabolism, and metabolic homeostasis; these are not the primary mechanistic targets of SS-31.
• Mitochondrial bioenergetics: SS-31 has a more direct connection to electron transport, respiratory efficiency, ATP production, membrane organization, and mitochondrial bioenergetics; MOTS-c influences cellular energetics more indirectly through metabolic signaling.
• Gene regulation: MOTS-c can translocate to the nucleus under metabolic stress and regulate stress-responsive nuclear gene expression; direct nuclear gene regulation is not considered a defining mechanism of SS-31.
• Research models: MOTS-c is particularly investigated in insulin resistance, obesity, exercise metabolism, aging, and metabolic stress, whereas SS-31 is particularly investigated in mitochondrial dysfunction, oxidative stress, impaired bioenergetics, cardiovascular and skeletal-muscle mitochondrial models.

What Is MOTS-c?

MOTS-c is a naturally occurring 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial 12S rRNA gene (MT-RNR1), with the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR). Unlike SS-31, which directly targets mitochondrial membrane cardiolipin, MOTS-c functions primarily as a mitochondrial signaling peptide involved in metabolic and cellular stress-response pathways.

MOTS-c is extensively studied in AMPK signaling, glucose metabolism, insulin sensitivity, cellular energy homeostasis, mitochondrial-nuclear communication, metabolic stress, skeletal-muscle metabolism, fatty-acid metabolism, mitochondrial function, cellular adaptation, and metabolic homeostasis.

What Is SS-31?

SS-31, also known as elamipretide, is a synthetic mitochondria-targeting tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH₂, where Dmt is 2,6-dimethyltyrosine. Unlike MOTS-c, which functions primarily as a mitochondrial-derived metabolic signaling peptide, SS-31 selectively interacts with cardiolipin in the inner mitochondrial membrane and is studied for its effects on mitochondrial membrane organization, electron transport, and oxidative phosphorylation.

SS-31 is extensively studied in cardiolipin interactions, mitochondrial bioenergetics, electron transport chain function, ATP production, mitochondrial membrane potential, reactive oxygen species (ROS), oxidative stress, mitochondrial respiration, cellular energetics, mitochondrial dysfunction, and cellular stress responses.

Molecular Structure & Modifications

Amino-Acid Sequence & Peptide Structure

• MOTS-c: 16-amino-acid peptide with the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR).
• SS-31: 4-amino-acid tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH₂, where Dmt represents 2,6-dimethyltyrosine.

MOTS-c is therefore four times longer by amino-acid count, while SS-31 is a compact synthetic tetrapeptide specifically designed for mitochondrial targeting.

2. Molecular Origin

• MOTS-c: A naturally occurring mitochondrial-derived peptide encoded by a short open reading frame within the mitochondrial 12S rRNA gene MT-RNR1.
• SS-31: A synthetic peptide belonging to the Szeto-Schiller (SS) class of mitochondria-targeting peptides.

This makes MOTS-c an endogenous mitochondrial signaling peptide, whereas SS-31 is an engineered mitochondrial-targeting peptide.

3. Natural vs Synthetic Amino Acids

MOTS-c consists of conventional proteinogenic amino acids encoded by its mitochondrial DNA sequence.

SS-31 incorporates the non-standard residue Dmt (2,6-dimethyltyrosine) together with D-arginine. These structural features distinguish SS-31 from naturally encoded peptides and contribute to its characteristic physicochemical and mitochondrial-targeting properties.

4. Charge & Mitochondrial Targeting

SS-31 has an alternating aromatic-cationic structure containing positively charged arginine and lysine residues alongside aromatic Dmt and phenylalanine. This architecture enables SS-31 to concentrate at the inner mitochondrial membrane and interact with cardiolipin without relying on the large membrane-potential-dependent accumulation characteristic of conventional lipophilic cations.

MOTS-c does not use the same cardiolipin-targeting structural mechanism. Instead, it functions as a mitochondrial-derived signaling peptide capable of participating in mitochondrial-to-nuclear and metabolic stress signaling.

5. Cardiolipin-Binding Structure

A defining structural feature of SS-31 is its ability to interact with cardiolipin, a phospholipid concentrated in the inner mitochondrial membrane. Its aromatic-cationic arrangement facilitates association with cardiolipin-containing membranes and links its structure directly to mitochondrial membrane and bioenergetic research.

MOTS-c is not characterized as a cardiolipin-binding peptide, making this one of the clearest molecular differences between MOTS-c and SS-31.

6. Molecular Weight

MOTS-c has a molecular weight of approximately 2.17 kDa, whereas SS-31 has a molecular weight of approximately 0.64 kDa.

Their substantial difference in molecular size reflects their distinct designs: MOTS-c is a longer endogenous signaling peptide, while SS-31 is a small synthetic tetrapeptide optimized for mitochondrial membrane interaction.

7. Structural Basis of Their Research Differences

The structural differences between MOTS-c and SS-31 correspond to fundamentally different approaches to mitochondrial regulation.

MOTS-c: Mitochondrial DNA-encoded 16-amino-acid peptide → metabolic and stress signaling → AMPK activation, glucose metabolism, mitochondrial-nuclear communication, and cellular energy homeostasis.

SS-31: Synthetic aromatic-cationic tetrapeptide → cardiolipin interaction and inner mitochondrial membrane targeting → mitochondrial respiration, electron transport, ATP production, membrane organization, and oxidative-stress research.

MOTS-c therefore functions primarily as a mitochondrial-derived signaling molecule, whereas SS-31 is structurally designed to interact directly with mitochondrial membranes and cardiolipin.

Mechanism of Actions Difference

1. Primary Mechanistic Difference

MOTS-c and SS-31 both influence mitochondrial function, but through fundamentally different mechanisms.

MOTS-c

• Functions primarily as a mitochondrial-derived signaling peptide
• Activates metabolic and cellular stress-response pathways
• Strongly associated with AMPK signaling
• Influences glucose utilization and cellular energy metabolism

SS-31

• Targets the inner mitochondrial membrane
• Selectively interacts with cardiolipin
• Influences electron transport chain organization and mitochondrial respiration
• Supports mitochondrial bioenergetics and limits oxidative stress

The fundamental difference is metabolic signaling and cellular adaptation with MOTS-c versus direct mitochondrial membrane and cardiolipin modulation with SS-31.

2. AMPK & Metabolic Signaling

MOTS-c: AMPK activation is a central feature of its proposed mechanism. MOTS-c can induce metabolic stress responses that activate AMPK, promoting glucose utilization, metabolic flexibility, and cellular adaptation to energetic stress.

SS-31: AMPK is not considered its primary molecular mechanism. Its effects on cellular metabolism are more closely linked to improving mitochondrial membrane function, respiration, and oxidative phosphorylation.

MOTS-c therefore has a more direct mechanistic connection to AMPK-mediated metabolic signaling.

3. Cardiolipin & Inner Mitochondrial Membrane

MOTS-c: Does not primarily function through direct cardiolipin binding and instead acts as a signaling molecule linking mitochondrial status with broader cellular metabolic responses.

SS-31: Selectively associates with cardiolipin in the inner mitochondrial membrane. This interaction influences membrane organization, respiratory-chain function, cristae architecture, and mitochondrial bioenergetics.

Direct cardiolipin interaction is therefore one of the defining mechanisms distinguishing SS-31 from MOTS-c.

4. Mitochondrial Respiration & Electron Transport

MOTS-c: Influences mitochondrial metabolism indirectly through metabolic signaling, substrate utilization, stress adaptation, and regulation of cellular energy homeostasis.

SS-31: Acts more directly on mitochondrial bioenergetics by interacting with cardiolipin and influencing electron transport chain organization, respiratory efficiency, and oxidative phosphorylation.

This makes SS-31 particularly relevant to research involving mitochondrial respiration and electron transport dysfunction.

5. Glucose & Energy Metabolism

MOTS-c: Strongly associated with glucose metabolism, insulin sensitivity, skeletal-muscle glucose uptake, and metabolic homeostasis. AMPK activation links MOTS-c signaling with cellular responses to changing nutrient and energy availability.

SS-31: Influences cellular energy metabolism primarily through mitochondrial bioenergetics rather than directly functioning as a metabolic signaling peptide.

MOTS-c therefore provides a more direct model for studying mitochondrial regulation of systemic and cellular metabolism.

6. Oxidative Stress & Reactive Oxygen Species

Both peptides are investigated in oxidative-stress research, but their upstream mechanisms differ.

MOTS-c: Influences cellular stress-response pathways that help cells adapt to metabolic and energetic stress.

SS-31: Acts closer to the source of mitochondrial oxidative stress by modifying cardiolipin-associated membrane processes, improving electron transport efficiency, and reducing excessive mitochondrial reactive oxygen species (ROS).

SS-31 therefore has a more direct mechanistic relationship with mitochondrial ROS production and redox homeostasis.

7. Mitochondrial-to-Nuclear Signaling

MOTS-c: Can translocate to the nucleus under metabolic stress and regulate nuclear gene expression, making mitochondrial-to-nuclear communication, or mitonuclear signaling, an important part of its biology.

SS-31: Is primarily associated with the mitochondria and does not depend on nuclear translocation as its defining mechanism. Its primary activity occurs through interactions involving the inner mitochondrial membrane and cardiolipin.

This distinguishes MOTS-c as a mitochondrial signaling messenger from SS-31 as a mitochondrial membrane-targeting peptide.

8. Overall Pharmacological Difference

MOTS-c and SS-31 ultimately converge on mitochondrial function and cellular energy homeostasis, but they act at different levels of mitochondrial biology.

MOTS-c: Mitochondrial-derived signaling → metabolic stress sensing → AMPK activation → glucose and energy metabolism → mitonuclear signaling and cellular adaptation.

SS-31: Mitochondrial targeting → cardiolipin interaction → inner mitochondrial membrane organization → electron transport and oxidative phosphorylation → ATP production and redox regulation.

MOTS-c therefore primarily models mitochondrial control of metabolic signaling and cellular adaptation, while SS-31 primarily models cardiolipin-dependent membrane function, mitochondrial bioenergetics, and oxidative-stress regulation.

Core Research Applications Difference

Core Research Applications

1. Metabolic Homeostasis & Insulin Sensitivity

MOTS-c is particularly studied in metabolic homeostasis, glucose regulation, obesity, and insulin-resistance models. The original MOTS-c study found that the peptide inhibited the folate cycle and de novo purine biosynthesis, leading to AMPK activation, while treatment in mice prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity.

SS-31 is also investigated in metabolic dysfunction, but its research focuses more directly on restoring mitochondrial bioenergetics rather than acting primarily through metabolic signaling pathways.

2. AMPK & Cellular Energy-Sensing Research

MOTS-c has a strong mechanistic connection to AMPK, a central regulator of cellular energy sensing and metabolic adaptation. Research on MOTS-c and exercise demonstrated interactions involving AMPK, PGC-1α, GLUT4, glucose metabolism, and insulin resistance, supporting its use in metabolic and skeletal-muscle energy research.

SS-31 does not primarily function through AMPK activation, providing a contrasting model in which mitochondrial energy production is targeted more directly at the inner mitochondrial membrane.

3. Cardiolipin & Mitochondrial Membrane Research

SS-31 is particularly relevant to research involving cardiolipin and inner mitochondrial membrane organization. Research on SS-31 and cardiolipin found that SS-31 selectively interacted with cardiolipin-containing membranes and modulated the cardiolipin–cytochrome c interaction, linking the peptide directly to mitochondrial membrane and respiratory-chain biology.

MOTS-c is not characterized as a cardiolipin-targeting peptide and instead influences mitochondrial function primarily through cellular signaling and metabolic adaptation.

4. Electron Transport & ATP Production

SS-31 has a stronger research emphasis on mitochondrial respiration, electron transport, oxidative phosphorylation, and ATP synthesis. Experimental research found that SS-31 restored cytochrome c reduction and mitochondrial oxygen consumption, increased state 3 respiration, and improved the efficiency of ATP synthesis.

MOTS-c affects cellular energetics through a different upstream mechanism involving AMPK, substrate metabolism, and metabolic signaling rather than direct modulation of electron transport.

5. Mitonuclear Signaling & Stress Adaptation

MOTS-c is particularly studied as a signaling molecule connecting mitochondrial status with nuclear gene expression. Cellular research demonstrated that MOTS-c translocated to the nucleus following metabolic stress and regulated stress-responsive nuclear genes in an AMPK-dependent manner, including genes containing antioxidant response elements associated with NRF2.

This mitochondrial-to-nuclear signaling represents a major distinction from SS-31, whose primary research mechanism centers on cardiolipin and inner mitochondrial membrane function.

6. Oxidative Stress & Mitochondrial ROS

Both peptides are relevant to oxidative-stress research, but through different mechanisms. MOTS-c participates in adaptive cellular stress signaling and nuclear gene regulation, while SS-31 acts more directly at mitochondrial membranes. Research on the SS-31 mechanism describes its interaction with cardiolipin, inhibition of cardiolipin-associated cytochrome c peroxidase activity, preservation of electron-carrier function, and protection of mitochondrial bioenergetics.

This makes SS-31 particularly relevant to mitochondrial ROS, cardiolipin oxidation, redox regulation, and oxidative damage research.

7. Skeletal Muscle & Exercise Metabolism

MOTS-c has substantial research relevance to skeletal-muscle metabolism and exercise-related signaling. Preclinical research found that exercise and MOTS-c were associated with AMPK/PGC-1α signaling, GLUT4 expression, improved glucose metabolism, and reduced insulin resistance.

MOTS-c therefore provides a useful research model for the relationship between mitochondria, skeletal muscle, exercise signaling, glucose utilization, and metabolic adaptation.

8. Mitochondrial Structure & Bioenergetic Dysfunction

SS-31 is extensively investigated in models where mitochondrial membrane architecture and bioenergetics are disrupted. Research in a mouse model of Barth syndrome found that SS-31 treatment improved abnormal cardiac mitochondrial morphology and affected proteins involved in mitochondrial dynamics and mitophagy.

This complements its broader research into cardiolipin, cristae organization, respiratory-chain function, ATP production, and mitochondrial membrane stability.

9. Lipid Metabolism & Metabolic Dysfunction

MOTS-c research also extends to lipid utilization and metabolic dysfunction. Metabolomic research in diet-induced obese mice found that MOTS-c improved insulin sensitivity, increased beta-oxidation, and altered sphingolipid, monoacylglycerol, and dicarboxylate metabolic pathways associated with obesity and type 2 diabetes models.

These metabolic effects further distinguish MOTS-c from SS-31, whose research emphasis is more directly centered on mitochondrial membrane integrity and bioenergetic efficiency.